Moreover, the research offers an experimental platform for the development of small molecule inhibitors of RBM39, such as aryl sulfonamides like indisulam, or RNA interference drugs, paving the way for the discovery of novel anti-tumor medications targeting RBM39. Here, RBM39 is linked to neoplasm.